Search

Your search keyword '"Theander, Thor G"' showing total 1,004 results

Search Constraints

Start Over You searched for: Author "Theander, Thor G" Remove constraint Author: "Theander, Thor G"
1,004 results on '"Theander, Thor G"'

Search Results

1. Broadly inhibitory antibodies to severe malaria virulence proteins

2. Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate

3. Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA

4. CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches

5. Bispecific T cell-engager targeting oncofetal chondroitin sulfate induces complete tumor regression and protective immune memory in mice

6. Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines

7. Author Correction: The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner

8. Mosaic and cocktail capsid-virus-like particle vaccines for induction of antibodies against the EPCR-binding CIDRα1 domain of PfEMP1.

9. Broadly inhibitory antibodies against severe malaria virulence proteins

10. Cryo-EM reveals the architecture of placental malaria VAR2CSA and provides molecular insight into chondroitin sulfate binding

11. Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity

12. Development of a bispecific immune engager using a recombinant malaria protein

15. Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines

19. A cVLP-based vaccine displaying full-length PCSK9 elicits a higher reduction in plasma PCSK9 than similar peptide-based cVLP vaccines

21. First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

23. The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner

25. Freeze-Drying of a Capsid Virus-like Particle-Based Platform Allows Stable Storage of Vaccines at Ambient Temperature

27. Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA

37. The specificity of the malarial VAR2CSA protein for chondroitin sulfate depends on 4-O-sulfation and ligand accessibility

42. PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum

43. The specificity of the malarial VAR2CSA protein for chondroitin sulfate depends on 4-O-sulfation and ligand accessibility

44. Detection of VAR2CSA‐captured colorectal cancer cells from blood samples by real‐time reverse transcription PCR

45. Head-to-head comparison of modular vaccines developed using different capsid virus-like particle backbones and antigen conjugation systems

46. Reduced birth weight caused by sextuple drug resistant Plasmodium falciparum infection in early second trimester

47. The immunogenicity of capsid-like particle vaccines in combination with different adjuvants using different routes of administration

Catalog

Books, media, physical & digital resources